cardiology careers collections past issues search home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 2


Figure 2 Changes in MMP-9, MCP-1, and PAI-1 in the 3 Treatment Groups

Arithmetic mean ± SEM for the relative change from baseline to 12 weeks in matrix metalloproteinase-9 (MMP-9), macrophage chemoattractant protein-1 (MCP-1), and plasminogen activator inhibitor-1 (PAI-1) in the 3 treatment groups (solid bars = pioglitazone; open bars = simvastatin; hatched bars = pioglitazone plus simvastatin): *p < 0.05 versus baseline; **p < 0.01 versus baseline; ***p < 0.001 versus baseline.





Right arrow Return to article

 
  cardiology careers collections past issues search home